Sinopharm Group Co., Ltd. (X2S)
FSX
1.79
-0.0080 (-0.44%)
Closed
Aug 24, 2026
Day's Range
1.791.79
52 wk Range
1.692.37
Financial Statements - X2S - Sinopharm Group Co., Ltd.
Revenue
575.16B▼ 1.6%
Net Income
10.83B▲ 3.9%Net Margin 1.9%
EBITDA
22.98B▼ 4.8%
Free Cash Flow
12.52B▲ 30.7%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 575.16B | 584.50B | 596.56B | 552.14B | 521.05B | 456.41B |
| Cost of Goods | 533.49B | 540.25B | 548.05B | 504.71B | 477B | 416.09B |
| Gross Profit | 41.67B | 44.25B | 48.51B | 47.43B | 44.05B | 40.32B |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | 17.07B | 17.77B | 22.27B | 22.54B | 21.44B | 19.78B |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | 14.79B | 14B | 19.51B | 18.56B | 17B | 15.59B |
| Income Tax | 3.96B | 3.57B | 4.50B | 4.21B | 3.93B | 3.50B |
| Net Income | 10.83B | 10.42B | 15B | 14.34B | 13.06B | 12.09B |
| EPS Basic | 2.29 | 2.26 | 2.9 | 2.73 | 2.49 | 2.31 |
| EPS Diluted | 2.29 | 2.26 | 2.9 | 2.73 | 2.49 | 2.31 |
| Basic Shares Outstanding | 3.12B | 3.12B | 3.12B | 3.12B | 23.52B | 23.52B |
| Diluted Shares Outstanding | 3.12B | 3.12B | 3.12B | 3.12B | 23.52B | 23.52B |
| Ebit | 17.09B | 16.73B | 22.46B | 22.08B | 20.75B | 19.02B |
| Ebitda | 22.98B | 24.14B | 28.66B | 28.17B | 26.81B | 24.80B |
| Net Income Continuous Operations | 14.79B | 14B | 19.51B | 18.56B | 17B | 15.59B |
| Minority Interests | -3.67B | -3.37B | -5.95B | -5.81B | -5.30B | -4.91B |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 74K |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
